LPCN · Lipocine Inc.
$2.11
-0.03 (-1.40%)
At close · Jul 29
Market Cap
$17.64M
Shares
8.24M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mahesh V. Patel | CEO | $986,336 |
| Dr. Nachiappan Chidambaram | Senior Vice President, Research and Development | $530,904 |
| Krista Fogarty | Principal Accounting Officer and Corporate Controller | $445,957 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mahesh V. Patel | CEO | $761,771 |
| Dr. Nachiappan Chidambaram | Senior Vice President, Research and Development | $413,789 |
| Krista Fogarty | Principal Accounting Officer and Corporate Controller | $340,588 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mahesh V. Patel | CEO | $860,343 |
| Dr. Nachiappan Chidambaram | Senior Vice President, Research and Development | $385,706 |
| Krista Fogarty | Principal Accounting Officer and Corporate Controller | $321,071 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mahesh V. Patel | CEO | $883,854 |
| Dr. Nachiappan Chidambaram | Senior Vice President, Research and Development | $352,197 |
| Krista Fogarty | Principal Accounting Officer and Corporate Controller | $297,779 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mahesh V. Patel | CEO | $1,099,582 |
| Dr. Nachiappan Chidambaram | Senior Vice President, Research and Development | $425,761 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| R. Dana Ono | Chairman of the Board and Lead Independent Director | Appointed | 2026-04-21 |
| Spyros Papapetropoulos | member of the Board | Resigned | 2026-04-21 |